# Trending Content OS — Daily Run
**Date:** 2026-09-25 | **Niche:** Health & Wellness

---

## 1. Preflight Summary

| Check | Status |
|---|---|
| All 7 configs + CLAUDE.md sections loaded | ✅ |
| `site_niche` / `target_audience` set | ✅ |
| `site_url` | ⚠️ Not configured — self-check skipped; competitor-list fallback used (configs/competitor_list.yaml) |
| `minimum_trend_strength_score` / `minimum_opportunity_score` | 50 / 55 (valid) |
| SerpAPI connected | ✅ |
| Google Trends | ✅ Available via injected pre-fetch (`search_velocity_source: google_trends`) |
| Google News Radar injected | ✅ 144 unique headlines across 12 queries |
| `data/deferred_topics.yaml` | No overdue `recheck_on` entries found |
| `data/run_history.yaml` recurrence check | Recall stories (thyroid, egg) and clinical-trial-equity stories flagged 2+ consecutive days — see notes |

**Decision:** `next_action: run_signal_listener` — full pipeline authorized.

---

## 2. Google News Radar Coverage Summary

Clustering the 144-headline radar into topic groups:

| Cluster | Disposition | Reasoning |
|---|---|---|
| **FDA/USDA recalls** (thyroid Class I, egg Class I, hand soap Class II, meat recall, H-E-B jalapeño Salmonella, glutathione injection) | **Split** — thyroid/egg/hand soap = **rejected (existing)**; meat recall + jalapeño recall = **retained (new)**; glutathione recall = **monitored** | Thyroid and egg recalls are continued syndication of stories already covered 09/20 and 09/24. The [meat recall (TODAY.com)](https://www.today.com/health/recall/massive-meat-recall-usda-inspection-false-label-rcna599435) and [H-E-B jalapeño recall (Dallas News)](https://www.dallasnews.com/news/public-health/article/h-e-b-jalape-o-recall-receives-fda-s-highest-22447175.php) are new products/classifications. [Glutathione recall (MedShadow)](https://medshadow.org/drug-updates-recalls/fda-recalls-and-warnings/third-glutathione-injection-recall-endotoxin-contamination/) lacks primary-source corroboration — routed to Skill 02b Monitor. |
| **Medical studies** (PATHFINDER 2, GLP-1 no medical need, REM sleep/83 diseases, alcohol use decline, Stanford mitochondrial disease, stroke/glioma) | **Split** — PATHFINDER 2 and GLP-1 = **rejected (existing)**; [REM sleep study (ScienceDaily)](https://www.sciencedaily.com/releases/2026/09/260923035930.htm), [alcohol use decline (Keck/USC)](https://news.keckmedicine.org/us-alcohol-use-falls-for-first-time-since-the-covid-19-pandemic-but-remains-above-pre-pandemic-levels/), [Stanford bone marrow transplant (Stanford Medicine)](https://med.stanford.edu/news/all-news/2026/09/stem-cell-mitochondrial-disease.html) = **retained**; stroke/glioma = **rejected (thin single-source, overlaps 09/18 brain-tumor coverage)** | PATHFINDER 2 and GLP-1 stories were covered in this exact form 09/23. Three studies are genuinely new. |
| **Clinical trial equity** (Black patient exclusion, ClinicalTrials.gov pregnancy checkbox) | **Rejected (existing)** | Identical structural-explainer story already covered 09/24. No new development beyond continued coverage. |
| **Ebola outbreak** (Congo vaccination, Moderna Phase 1 trial) | **Retained as update** | [Moderna Phase 1 Ebola vaccine trial (ABC News)](https://abcnews.com/Health/moderna-begins-phase-1-clinical-trial-ebola-vaccine/story?id=135365177) is a new specific development on the outbreak story covered 09/23. |
| **Wellness/local institutional** (Baltimore men's health event, Haines AK funding, UC Davis, Coast Guard EAP, Dartmouth, Marquette) | **Rejected — off-category** | Local hospital/institutional news, excluded category, insufficient national audience relevance. |
| **Pro-nicotine wellness rebrand** (WaPo pulmonologist column, The Conversation explainer) | **Rejected (existing)** | Same story already covered 09/23; new outlet adds framing but no new development. |
| **CDC Youth Health in Focus (YRBS data)** | **Monitored** | Cleared category fit but `trend_strength_score` (48) fell just under the 50 minimum — evergreen resource, not fresh news. Deferred, not rejected outright. |
| **Screwworm (USDA)** | **Rejected — edge/off-category** | Livestock biosecurity; static page, no breaking trigger, weak audience relevance. |
| **Healthcare economics** (insurance-skipping, Yale premium study), **WHO AI ethics oversight**, **Google Health app tools**, **OpenAI breach**, **FDA nominee hearing**, obituary | **Rejected — off-category/edge** | Business, policy-abstract, tech-product, or non-health-content angle; low core-category fit per category_rules.yaml. |

---

## 3. Signal Summary

```yaml
signal_summary:
  run_started_at: "2026-09-25T00:00:00Z"
  run_completed_at: "2026-09-25T00:45:00Z"
  total_signals_reviewed: 144
  total_signals_retained: 7
  total_rejected: 137
  google_trends_available: true
  search_velocity_source: "google_trends"
  rejection_breakdown:
    off_category: 41
    brand_safety: 0
    duplicate: 11
    weak_signal: 6
    unverified_claim: 1
    other: 78   # local/institutional, business/policy-adjacent, thin single-source
  highest_priority_topic: "USDA meat recall — 160,000 lbs, lack of inspection, highest risk classification"
  strongest_signal_source: "USDA/TODAY.com (implied primary agency notice)"
  tools_unavailable: []
  notes: >
    Recall stories from prior runs (thyroid Class I, egg Class I, hand soap Class II) are
    recurring 2nd/3rd consecutive appearances in the radar as syndication continues — flagged
    per recurrence check, correctly suppressed as existing. Clinical-trial-equity story also
    recurring — suppressed. Two NEW recalls (meat, jalapeño) surfaced today and were retained.
    Google Trends interest for "diet," "nutrition," and "mental health" remains elevated
    (67-70) but rising-related-query lists were dominated by unrelated commercial/travel
    queries — low signal quality from Trends this cycle; News Radar carried the actionable
    load today.
```

---

## 4. Skill 02b — Health Claim Verification Gate Routing Summary

| Topic | Risk type | Gate result | Notes |
|---|---|---|---|
| USDA meat recall (160k lbs) | Recall | **Pass — Medium confidence cap** | Breaking-recall exception applied; primary USDA/FSIS notice not directly retrieved. Recommend verifying FSIS notice before publishing. |
| H-E-B jalapeño Salmonella recall | Recall | **Pass — Medium confidence cap** | Same exception applied; FDA notice implied but not directly retrieved. |
| Glutathione injection recall (3rd in series) | Recall | **Monitor → P5** | Only one weak secondary source (MedShadow); breaking-recall exception requires 3+ credible sources including an FDA/USDA/AP/Reuters-tier outlet. Not present. Exits to Monitor pending stronger sourcing. |
| REM sleep study (83 diseases) | Medical study | **Pass, with overstatement note** | ScienceDaily names underlying institution/journal. "83 diseases" framing risks scale distortion — mild overstatement flagged, not material. |
| Stanford bone marrow transplant (mitochondrial disease) | Drug/treatment claim | **Pass** | Direct institutional press release (Stanford Medicine) = primary source. Claim matches. |
| Moderna Ebola Phase 1 trial | Clinical trial | **Pass** | Manufacturer statement (Moderna) via ABC News; corroborated by ongoing WHO/Congo outbreak context. |
| Alcohol use decline (Keck/USC) | Lower-risk (data release, not drug/dosage claim) | **Not applicable** | Skipped gate — population survey trend, not a treatment/dosage/supplement claim. |
| CDC Youth Health in Focus | Lower-risk | **Not applicable** | Skipped gate — data resource, not a specific claim. |

---

## 5. Final Editorial Priority Board

| Priority | Topic | Timing | Trend | Opp | Discover | Urgency | Confidence |
|---|---|---|---|---|---|---|---|
| **P1** | USDA meat recall — lack of inspection | Immediate | 68 | 81 | 4 | today | medium |
| **P2** | H-E-B jalapeño Salmonella recall | Immediate | 64 | 78 | 4 | today | medium |
| **P2** | Moderna begins Phase 1 Ebola vaccine trial | Short-term | 50 | 73 | 4 | today | medium |
| **P3** | REM sleep linked to lower risk of 83 diseases | Scheduled | 50 | 76 | 3 | this_week | low |
| **P3** | U.S. alcohol use falls for first time since pandemic | Scheduled | 50 | 68 | 3 | this_week | medium |
| **P4** | Stanford: bone marrow transplant treats mitochondrial disease | Evergreen | 52 | 68 | 4 | this_week | low |
| **P5 (Monitor)** | Third glutathione injection recall (endotoxin) | Monitor | — | — | — | — | — |
| **Monitor** | CDC Youth Health in Focus (YRBS data) | Monitor | 48 | 60 | — | evergreen | — |

```yaml
summary:
  total_topics: 8
  high_priority_count: 3
  immediate_actions: "Publish meat recall explainer today; fast-follow with jalapeño recall and Ebola trial update within 24-48h."
pass_to_next_layer: false
```

---

## 6. Editorial Briefs

### P1 — USDA Meat Recall (160,000 lbs, Lack of Inspection)
```yaml
priority_level: P1
publish_timing: immediate
topic: "USDA recalls 160,000+ lbs of meat over lack of federal inspection — highest risk classification"
primary_entity: "USDA/FSIS meat recall"
signal_type: recall
allowed_category: "FDA and CDC regulatory updates"
trend_strength_score: 68
opportunity_score: 81
discover_score: 4
urgency: today
confidence: medium
content_status: new
source_count: 1
recommended_angle: "What 'lack of inspection' actually means and what shoppers need to check right now — practical, urgent explainer, not a food-safety scare piece."
why_now: "Breaking today; USDA classified it highest risk. No competitor explainer content exists yet."
primary_headline: "USDA Recalls 160,000+ Pounds of Meat Over Missing Inspection — Here's What to Check"
next_steps: "Verify FSIS recall notice directly (lot codes, distribution states) before publishing; confirm classification language matches USDA, not just aggregator framing."
notes: "⚠️ Integrity note: primary FSIS notice not directly retrieved — confirmed via TODAY.com only. Verify before publishing per breaking-recall exception."
sources:
  - { publisher: "TODAY.com", url: "https://www.today.com/health/recall/massive-meat-recall-usda-inspection-false-label-rcna599435", tier: 2, used_for: "Recall announcement" }
```

### P2 — H-E-B Jalapeño Salmonella Recall
```yaml
priority_level: P2
publish_timing: immediate
topic: "H-E-B jalapeño products recalled — Class I Salmonella risk"
primary_entity: "H-E-B jalapeño recall"
signal_type: recall
allowed_category: "nutrition and diet science / FDA regulatory updates"
trend_strength_score: 64
opportunity_score: 78
discover_score: 4
urgency: today
confidence: medium
content_status: new
source_count: 1
recommended_angle: "Direct, actionable: which products, what stores, what to do if you bought them — paired with a broader note on this week's cluster of food-safety Class I recalls."
why_now: "Escalated to Class I today; regional retailer with wide distribution."
primary_headline: "H-E-B Jalapeño Recall Escalates to FDA's Highest Risk Level — What to Know"
next_steps: "Confirm FDA recall notice directly; verify product SKUs/lot numbers before publishing."
notes: "⚠️ Integrity note: single secondary source (Dallas News); confirm FDA.gov notice directly."
sources:
  - { publisher: "Dallas News", url: "https://www.dallasnews.com/news/public-health/article/h-e-b-jalape-o-recall-receives-fda-s-highest-22447175.php", tier: 2, used_for: "Recall classification" }
```

### P2 — Moderna Phase 1 Ebola Vaccine Trial
```yaml
priority_level: P2
publish_timing: short_term
topic: "Moderna begins Phase 1 trial of Ebola vaccine matched to DRC outbreak strain"
primary_entity: "Moderna Ebola vaccine"
signal_type: clinical_trial
allowed_category: "infectious disease"
trend_strength_score: 50
opportunity_score: 73
discover_score: 4
urgency: today
confidence: medium
content_status: update
source_count: 1
recommended_angle: "Update piece: connect to the ongoing Congo Ebola outbreak/vaccination effort (covered 09/23) — explain what Phase 1 means for timeline and who's protected now vs. later."
why_now: "New development on active outbreak story — Moderna's first human trial specifically targeting the current epicenter strain."
primary_headline: "Moderna Starts Human Trial of Ebola Vaccine Targeting Current Outbreak Strain"
next_steps: "Cross-reference ClinicalTrials.gov for trial registration; link to WHO/PBS coverage of the vaccination campaign for continuity."
notes: "No integrity flags. Frame trial phase clearly — Phase 1 is safety/dosing, not efficacy confirmation."
sources:
  - { publisher: "ABC News", url: "https://abcnews.com/Health/moderna-begins-phase-1-clinical-trial-ebola-vaccine/story?id=135365177", tier: 2, used_for: "Trial announcement" }
  - { publisher: "PBS (prior outbreak coverage)", url: "https://www.pbs.org/newshour/world/congo-begins-ebola-vaccinations-for-health-workers-in-the-epicenter-of-the-outbreak", tier: 1, used_for: "Outbreak context" }
```

### P3 — REM Sleep and Disease Risk
```yaml
headline: "More REM Sleep Linked to Lower Risk of 83 Diseases — What the Study Actually Found"
topic: "REM sleep and reduced disease risk (large cohort study)"
angle: "Lead with the actual study language and cohort design before the headline number — this is a correlational finding, and '83 diseases' invites overstatement."
key_data_points: ["Large-cohort association between REM sleep proportion and reduced incidence across a broad disease panel"]
integrity_flags: ["⚠️ Integrity note: coverage risks scale distortion — single study, association not causation, needs framing discipline"]
expert_type_needed: "Sleep medicine specialist (board-certified) to contextualize causation vs. association"
seo: { primary_keyword: "REM sleep disease risk study", format: "explainer", serp_difficulty: "Medium" }
sources:
  - { publisher: "ScienceDaily", url: "https://www.sciencedaily.com/releases/2026/09/260923035930.htm" }
priority_level: P3
publish_timing: scheduled
primary_entity: "REM sleep study"
signal_type: study_or_research
allowed_category: "sleep science"
trend_strength_score: 50
opportunity_score: 76
discover_score: 3
urgency: this_week
confidence: low
content_status: new
source_count: 1
recommended_angle: "Explain the actual study design and caveat the headline number."
why_now: "Fresh study coverage, thin competing explainer content."
next_steps: "Identify underlying journal/institution before drafting; single-source confidence is low."
```

### P3 — U.S. Alcohol Use Decline
```yaml
headline: "U.S. Alcohol Use Falls for First Time Since the Pandemic — But Still Above Pre-2020 Levels"
topic: "Alcohol consumption trend reversal post-pandemic"
angle: "Data-driven trend piece: what's driving the decline (GLP-1s? sober-curious movement? economics?) with appropriate caveats on self-reported survey data."
key_data_points: ["First measured decline in U.S. alcohol use since COVID-19 pandemic onset; still elevated vs. pre-pandemic baseline"]
integrity_flags: []
expert_type_needed: "Epidemiologist or public health researcher on substance use trends"
seo: { primary_keyword: "alcohol use decline 2026", format: "data explainer", serp_difficulty: "Easy" }
sources:
  - { publisher: "Keck Medicine of USC", url: "https://news.keckmedicine.org/us-alcohol-use-falls-for-first-time-since-the-covid-19-pandemic-but-remains-above-pre-pandemic-levels/" }
priority_level: P3
publish_timing: scheduled
primary_entity: "U.S. alcohol consumption trend"
signal_type: study_or_research
allowed_category: "public health and epidemiology"
trend_strength_score: 50
opportunity_score: 68
discover_score: 3
urgency: this_week
confidence: medium
content_status: new
source_count: 1
recommended_angle: "Trend-reversal data story with causal-speculation caveats."
why_now: "New institutional data release; no competing coverage yet."
next_steps: "Identify underlying survey source (NSDUH or equivalent) for direct citation."
```

### P4 — Stanford Bone Marrow Transplant for Mitochondrial Disease
```yaml
headline: "Stanford Study: Bone Marrow Transplants Show Surprising Promise for Mitochondrial Disease"
topic: "Bone marrow transplant as treatment approach for mitochondrial disease"
angle: "Narrow but durable explainer — what mitochondrial disease is, why this approach is unexpected, and how early-stage this finding is."
key_data_points: ["Stanford Medicine study describes bone marrow transplant as a novel treatment avenue for mitochondrial disease"]
integrity_flags: ["⚠️ Integrity note: single institutional source — confirm peer-reviewed publication status and trial stage before framing as established treatment."]
expert_type_needed: "Geneticist or mitochondrial disease specialist"
seo: { primary_keyword: "bone marrow transplant mitochondrial disease", format: "explainer", serp_difficulty: "Easy" }
sources:
  - { publisher: "Stanford Medicine", url: "https://med.stanford.edu/news/all-news/2026/09/stem-cell-mitochondrial-disease.html" }
priority_level: P4
publish_timing: evergreen
primary_entity: "Stanford mitochondrial disease study"
signal_type: study_or_research
allowed_category: "chronic disease management"
trend_strength_score: 52
opportunity_score: 68
discover_score: 4
urgency: this_week
confidence: low
content_status: new
source_count: 1
recommended_angle: "Careful early-research framing, not a breakthrough-cure narrative."
why_now: "Novel institutional finding, thin coverage elsewhere, evergreen value."
next_steps: "Confirm study publication (journal/DOI) before drafting; single-source confidence is low."
```

---

## 7. Rejected Topics Log (selected — full list available on request)

| Topic | Reason |
|---|---|
| FDA thyroid recall Class I upgrade | `existing` — covered 09/24, no new development |
| 19M-egg Salmonella recall Class I | `existing` — covered 09/20 |
| Hand soap recall Class II | `existing` — covered 09/19 |
| Nature: girls' mental health outcomes | `existing` — covered 09/24 |
| Clinical trial exclusion of Black/pregnant patients | `existing` — covered 09/24 |
| PATHFINDER 2 multi-cancer blood test | `existing` — covered 09/23 |
| GLP-1 use without medical need | `existing` — covered 09/23 |
| Pro-nicotine wellness rebrand (Conversation piece) | `existing` — covered 09/23, no new development |
| Third glutathione injection recall | `unverified_claim` → **Monitor (P5)** — insufficient sourcing per Skill 02b |
| CDC Youth Health in Focus (YRBS) | `weak_signal` — trend_strength 48 < 50 threshold; deferred, not deleted |
| Stroke promotes glioma growth study | `weak_signal` — single low-tier source, overlaps 09/18 brain-tumor coverage |
| Screwworm (USDA) | `off_category` — low audience relevance, no fresh trigger |
| Healthcare insurance/premium stories (WaPo, Yale) | `off_category` — economics/policy-adjacent, low core-category fit |
| WHO AI ethics oversight in health research | `off_category` — abstract/institutional, low audience relevance |
| Google Health app safety tools | `off_category` — tech product marketing |
| OpenAI breach of Australian health dept | `off_category` — cybersecurity, not health content |
| FDA nominee Senate hearing | `off_category` — political/process story |
| Local wellness center/event stories (Baltimore, Haines, UC Davis, Coast Guard, Dartmouth, Marquette) | `off_category` — excluded local/institutional news |

---

## 8. Integrity Flags — Consolidated

⚠️ USDA meat recall — primary FSIS notice not directly retrieved (breaking-recall exception, Medium confidence cap).
⚠️ H-E-B jalapeño recall — primary FDA notice not directly retrieved (breaking-recall exception, Medium confidence cap).
⚠️ REM sleep study — "83 diseases" framing risks scale distortion; lead with actual study language, flag association vs. causation.
⚠️ Stanford mitochondrial disease study — single institutional source; confirm peer-reviewed/trial-stage status before framing as established treatment.
⚠️ Glutathione recall — insufficient sourcing to verify; held at Monitor, not published.

---

## 9. Run Notes

- **Recurrence flag confirmed**: Recall coverage (thyroid, egg) and clinical-trial-equity coverage each appeared in 2+ consecutive runs with no new development — correctly suppressed today rather than re-scored, per Daily Run Step 2 cross-run dedup logic.
- **Google Trends signal was weak this cycle** — rising-related-query lists were dominated by unrelated commercial/travel terms across nearly every seed keyword; News Radar carried the actionable signal load. This is disclosed rather than papered over.
- **`site_url` not configured** — self-check skipped; competitor-list fallback (Healthline, WebMD, STAT, NYT Well, etc.) used to inform SERP-gap judgment on all retained candidates.
- Two low-confidence P3/P4 briefs (REM sleep, Stanford mitochondrial) are single-sourced; recommend a same-day secondary-source check before drafting rather than treating scores as final.
- Dashboard/history archival: this output should be written to `outputs/daily_newsroom_dashboard/2026-09-25.html` and appended to `data/run_history.yaml` per standard workflow.